Chinese Journal of Chromatography ›› 2026, Vol. 44 ›› Issue (9): 1048-1058.DOI: 10.3724/SP.J.1123.2025.12005
• Articles • Previous Articles Next Articles
Received:2025-12-02
Online:2026-09-08
Published:2026-09-17
Supported by:CLC Number:
WEI Qi, SU Fuhai, ZHU Xin. Determination of 15 fentanyl analogs and amphetamine-type stimulants in hair by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry[J]. Chinese Journal of Chromatography, 2026, 44(9): 1048-1058.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chrom-china.com/EN/10.3724/SP.J.1123.2025.12005
| Drug name | Retention time/ min | Mr | Precursor ion (m/z) | Product ion (m/z) | Cone voltage/V | Collision energy/V |
|---|---|---|---|---|---|---|
| Norfentanyl | 5.36 | 232.32 | 233.25 | 84.25* | 82 | 18 |
| Acetylfentanyl | 8.75 | 322.45 | 323.31 | 188.29* | 10 | 20 |
| 105.23 | 10 | 32 | ||||
| Ocfentanil | 11.74 | 370.47 | 371.33 | 188.29* | 10 | 24 |
| 105.23 | 10 | 34 | ||||
| Thiofentanyl | 13.11 | 342.50 | 343.23 | 194.27* | 16 | 20 |
| 111.21 | 16 | 46 | ||||
| Fentanyl | 9.59 | 336.48 | 337.34 | 188.29* | 4 | 20 |
| 105.23 | 4 | 34 | ||||
| 4-Fluorofentanyl | 10.35 | 354.47 | 355.33 | 188.29* | 8 | 26 |
| 105.23 | 8 | 34 | ||||
| Isobutyrylfentanyl | 8.81 | 350.51 | 351.37 | 188.29* | 16 | 24 |
| 105.23 | 16 | 34 | ||||
| 4-Fluorobutyrylfentanyl | 14.38 | 368.50 | 369.36 | 188.29* | 6 | 24 |
| 105.23 | 6 | 36 | ||||
| Tetrahydrofuranylfentanyl | 15.25 | 378.52 | 379.29 | 188.29* | 94 | 38 |
| 105.23 | 94 | 22 | ||||
| Amphetamine (AP) | 1.35 | 135.00 | 137.10 | 92.15* | 55 | 25 |
| 119.00 | 55 | 15 | ||||
| Methamphetamine (MA) | 2.74 | 149.23 | 148.24 | 133.24* | 64 | 18 |
| 117.26 | 64 | 16 | ||||
| 3,4-Methylenedioxyethylamphetamine (MDEA) | 5.17 | 207.00 | 208.22 | 105.23* | 28 | 22 |
| 132.85 | 28 | 24 | ||||
| 3,4-Methylenedioxymethamphetamine (MDMA) | 4.44 | 194.00 | 194.22 | 163.27* | 32 | 12 |
| 105.23 | 32 | 22 | ||||
| Tenamfetamine (MDA) | 4.00 | 179.20 | 181.10 | 135.00 | 70 | 26 |
| 164.20* | 70 | 13 | ||||
| Ephedrine | 2.72 | 148.00 | 148.16 | 114.91 | 42 | 16 |
| 133.24* | 42 | 16 |
Table 1 MS parameters of fentanyl analogues and amphetamine-type stimulants in LC-MS/MS
| Drug name | Retention time/ min | Mr | Precursor ion (m/z) | Product ion (m/z) | Cone voltage/V | Collision energy/V |
|---|---|---|---|---|---|---|
| Norfentanyl | 5.36 | 232.32 | 233.25 | 84.25* | 82 | 18 |
| Acetylfentanyl | 8.75 | 322.45 | 323.31 | 188.29* | 10 | 20 |
| 105.23 | 10 | 32 | ||||
| Ocfentanil | 11.74 | 370.47 | 371.33 | 188.29* | 10 | 24 |
| 105.23 | 10 | 34 | ||||
| Thiofentanyl | 13.11 | 342.50 | 343.23 | 194.27* | 16 | 20 |
| 111.21 | 16 | 46 | ||||
| Fentanyl | 9.59 | 336.48 | 337.34 | 188.29* | 4 | 20 |
| 105.23 | 4 | 34 | ||||
| 4-Fluorofentanyl | 10.35 | 354.47 | 355.33 | 188.29* | 8 | 26 |
| 105.23 | 8 | 34 | ||||
| Isobutyrylfentanyl | 8.81 | 350.51 | 351.37 | 188.29* | 16 | 24 |
| 105.23 | 16 | 34 | ||||
| 4-Fluorobutyrylfentanyl | 14.38 | 368.50 | 369.36 | 188.29* | 6 | 24 |
| 105.23 | 6 | 36 | ||||
| Tetrahydrofuranylfentanyl | 15.25 | 378.52 | 379.29 | 188.29* | 94 | 38 |
| 105.23 | 94 | 22 | ||||
| Amphetamine (AP) | 1.35 | 135.00 | 137.10 | 92.15* | 55 | 25 |
| 119.00 | 55 | 15 | ||||
| Methamphetamine (MA) | 2.74 | 149.23 | 148.24 | 133.24* | 64 | 18 |
| 117.26 | 64 | 16 | ||||
| 3,4-Methylenedioxyethylamphetamine (MDEA) | 5.17 | 207.00 | 208.22 | 105.23* | 28 | 22 |
| 132.85 | 28 | 24 | ||||
| 3,4-Methylenedioxymethamphetamine (MDMA) | 4.44 | 194.00 | 194.22 | 163.27* | 32 | 12 |
| 105.23 | 32 | 22 | ||||
| Tenamfetamine (MDA) | 4.00 | 179.20 | 181.10 | 135.00 | 70 | 26 |
| 164.20* | 70 | 13 | ||||
| Ephedrine | 2.72 | 148.00 | 148.16 | 114.91 | 42 | 16 |
| 133.24* | 42 | 16 |
| Drug name | Characteristic ions (m/z) | Retention time/min |
|---|---|---|
| Norfentanyl | 83*, 120, 159, 175 | 15.84 |
| Acetylfentanyl | 231*, 146, 188 | 20.59 |
| Ocfentanil | 279*, 176, 280 | 24.19 |
| Thiofentanyl | 245*, 146, 93 | 23.22 |
| Fentanyl | 245*, 146, 189, 280 | 22.89 |
| 4-Fluorofentanyl | 263*, 164, 220 | 21.21 |
| Isobutyrylfentanyl | 259*, 146, 189 | 21.92 |
| 4-Fluorobutyrylfentanyl | 164*, 277, 207 | 23.74 |
| Tetrahydrofuranylfentanyl | 287*, 189, 146, 158 | 24.86 |
| AP | 44*, 91, 117, 65 | 6.18 |
| MA | 58*, 91, 56 | 6.18 |
| MDEA | 72*, 135, 136, 77 | 10.78 |
| MDMA | 58*, 77, 59, 135 | 10.08 |
| MDA | 44*, 136, 77, 51 | 10.18 |
| Ephedrine | 58*, 77, 105 | 8.65 |
Table 2 Characteristic ions of fentanyl analogues and amphetamine-type stimulants in GC-MS
| Drug name | Characteristic ions (m/z) | Retention time/min |
|---|---|---|
| Norfentanyl | 83*, 120, 159, 175 | 15.84 |
| Acetylfentanyl | 231*, 146, 188 | 20.59 |
| Ocfentanil | 279*, 176, 280 | 24.19 |
| Thiofentanyl | 245*, 146, 93 | 23.22 |
| Fentanyl | 245*, 146, 189, 280 | 22.89 |
| 4-Fluorofentanyl | 263*, 164, 220 | 21.21 |
| Isobutyrylfentanyl | 259*, 146, 189 | 21.92 |
| 4-Fluorobutyrylfentanyl | 164*, 277, 207 | 23.74 |
| Tetrahydrofuranylfentanyl | 287*, 189, 146, 158 | 24.86 |
| AP | 44*, 91, 117, 65 | 6.18 |
| MA | 58*, 91, 56 | 6.18 |
| MDEA | 72*, 135, 136, 77 | 10.78 |
| MDMA | 58*, 77, 59, 135 | 10.08 |
| MDA | 44*, 136, 77, 51 | 10.18 |
| Ephedrine | 58*, 77, 105 | 8.65 |
Fig. 3 Influences of different extraction parameters on the content of methamphetaminea. extraction temperature and extraction time; b. extraction temperature and liquid-to-solid ratio; c. extraction temperature and hydrochloric acid concentration; d. extraction time and liquid-to-solid ratio; e. extraction time and hydrochloric acid concentration; f. liquid-to-solid ratio and hydrochloric acid concentration.
| Drug | GC-MS | LC-MS/MS | ||||
|---|---|---|---|---|---|---|
| Linear range/(ng/mg) | Regression equation | r | Linear range/(ng/mg) | Regression equation | r | |
| Norfentanyl | 0.4-4.5 | y=0.1311x+0.1568 | 0.9998 | 0.01-0.2 | y=21.173x+0.1193 | 0.9997 |
| Acetylfentanyl | 0.9-4.5 | y=0.2019x+0.3706 | 0.9996 | 0.01-0.2 | y=61.131x+0.3503 | 0.9996 |
| Isobutyrylfentanyl | 0.4-4.5 | y=0.27x+0.6094 | 0.9997 | 0.01-0.2 | y=51.327x+1.2441 | 0.9996 |
| 4-Fluorofentanyl | 0.4-4.5 | y=0.2233x+0.4528 | 0.9996 | 0.01-0.2 | y=71.813x+0.0265 | 0.9995 |
| Ocfentanil | 0.4-4.5 | y=0.2182x+0.4271 | 0.9997 | 0.01-0.2 | y=84.916x+0.462 | 0.9995 |
| Thiofentanyl | 0.4-4.5 | y=0.175x+0.4698 | 0.9996 | 0.01-0.2 | y=45.938x+0.1992 | 0.9995 |
| 4-Fluorobutyrylfentanyl | 0.4-4.5 | y=0.1424x+0.3142 | 0.9997 | 0.01-0.2 | y=16.077x+3.8265 | 0.9998 |
| Tetrahydrofuranylfentanyl | 0.9-4.5 | y=0.1195x+0.2369 | 0.9995 | 0.01-0.2 | y=31.942x+0.0672 | 0.9997 |
| Fentanyl | 0.4-4.5 | y=0.1425x+0.3061 | 0.9996 | 0.01-0.2 | y=56.917x+0.1109 | 0.9999 |
| AP | 0.9-4.3 | y=0.5144x+0.9685 | 0.9996 | 0.06-0.5 | y=0.1779x+0.0163 | 0.9995 |
| MA | 0.9-4.5 | y=1.0571x+1.0671 | 0.9998 | 0.01-0.2 | y=7.689x-0.0435 | 0.9997 |
| MDEA | 0.9-4.4 | y=1.056x+4.1112 | 0.9996 | 0.01-0.2 | y=23.794x+0.1312 | 0.9996 |
| MDMA | 0.9-4.4 | y=0.6487x+2.0984 | 0.9995 | 0.01-0.2 | y=38.361x+0.12 | 0.9998 |
| Ephedrine | 0.9-4.4 | y=0.604x+0.8299 | 0.9997 | 0.01-0.2 | y=10.336x-0.0034 | 0.9999 |
| MDA | 0.9-4.4 | y=0.3614x+0.5927 | 0.9997 | 0.06-0.5 | y=0.0566x+0.0062 | 0.9996 |
Table 3 Linear relationships of the 15 target substances
| Drug | GC-MS | LC-MS/MS | ||||
|---|---|---|---|---|---|---|
| Linear range/(ng/mg) | Regression equation | r | Linear range/(ng/mg) | Regression equation | r | |
| Norfentanyl | 0.4-4.5 | y=0.1311x+0.1568 | 0.9998 | 0.01-0.2 | y=21.173x+0.1193 | 0.9997 |
| Acetylfentanyl | 0.9-4.5 | y=0.2019x+0.3706 | 0.9996 | 0.01-0.2 | y=61.131x+0.3503 | 0.9996 |
| Isobutyrylfentanyl | 0.4-4.5 | y=0.27x+0.6094 | 0.9997 | 0.01-0.2 | y=51.327x+1.2441 | 0.9996 |
| 4-Fluorofentanyl | 0.4-4.5 | y=0.2233x+0.4528 | 0.9996 | 0.01-0.2 | y=71.813x+0.0265 | 0.9995 |
| Ocfentanil | 0.4-4.5 | y=0.2182x+0.4271 | 0.9997 | 0.01-0.2 | y=84.916x+0.462 | 0.9995 |
| Thiofentanyl | 0.4-4.5 | y=0.175x+0.4698 | 0.9996 | 0.01-0.2 | y=45.938x+0.1992 | 0.9995 |
| 4-Fluorobutyrylfentanyl | 0.4-4.5 | y=0.1424x+0.3142 | 0.9997 | 0.01-0.2 | y=16.077x+3.8265 | 0.9998 |
| Tetrahydrofuranylfentanyl | 0.9-4.5 | y=0.1195x+0.2369 | 0.9995 | 0.01-0.2 | y=31.942x+0.0672 | 0.9997 |
| Fentanyl | 0.4-4.5 | y=0.1425x+0.3061 | 0.9996 | 0.01-0.2 | y=56.917x+0.1109 | 0.9999 |
| AP | 0.9-4.3 | y=0.5144x+0.9685 | 0.9996 | 0.06-0.5 | y=0.1779x+0.0163 | 0.9995 |
| MA | 0.9-4.5 | y=1.0571x+1.0671 | 0.9998 | 0.01-0.2 | y=7.689x-0.0435 | 0.9997 |
| MDEA | 0.9-4.4 | y=1.056x+4.1112 | 0.9996 | 0.01-0.2 | y=23.794x+0.1312 | 0.9996 |
| MDMA | 0.9-4.4 | y=0.6487x+2.0984 | 0.9995 | 0.01-0.2 | y=38.361x+0.12 | 0.9998 |
| Ephedrine | 0.9-4.4 | y=0.604x+0.8299 | 0.9997 | 0.01-0.2 | y=10.336x-0.0034 | 0.9999 |
| MDA | 0.9-4.4 | y=0.3614x+0.5927 | 0.9997 | 0.06-0.5 | y=0.0566x+0.0062 | 0.9996 |
Fig. 4 LC-MS/MS chromatogram of the 15 target substances in hair samples 1. ephedrine; 2. MA; 3. MDA; 4. MDMA;5. MDEA; 6. norfentanyl; 7. acetylfentanyl; 8. 4-fluorofentanyl; 9. isobutyrylfentanyl; 10. fentanyl; 11. thiofentanyl; 12. 4-fluorobutyrylfentanyl; 13. ocfentanil; 14. tetrahydrofuranylfentanyl.
Fig. 5 GC-MS chromatograms of the 15 target substances in hair samples 1. MA; 2. ephedrine; 3. MDA; 4. MDMA;5. MDEA; 6. norfentanyl; 7. acetylfentanyl; 8. fentanyl; 9. thiofentanyl; 10. isobutyrylfentanyl; 11. 4-fluorofentanyl; 12. 4-fluorobutyrylfentanyl; 13. ocfentanil; 14. tetrahydrofuranylfentanyl.
| Drug name | LC-MS/MS (n=3) | GC-MS (n=3) | Deviation/% | Average value/(ng/mg) | ||
|---|---|---|---|---|---|---|
| Average value/(ng/mg) | RSD/% | Average value/(ng/mg) | RSD/% | |||
| Norfentanyl | 1.012 | 1.6 | 1.087 | 3.7 | -7.1 | 1.050 |
| Acetylfentanyl | 4.788 | 0.6 | 4.821 | 2.0 | -0.7 | 4.805 |
| Isobutyrylfentanyl | 4.826 | 0.3 | 4.816 | 1.9 | 0.2 | 4.821 |
| 4-Fluorofentanyl | 5.830 | 0.2 | 5.786 | 1.6 | 0.8 | 5.808 |
| Ocfentanil | 3.188 | 1.1 | 3.031 | 2.2 | 5.1 | 3.110 |
| Thiofentanyl | 5.010 | 0.6 | 4.925 | 2.0 | 1.7 | 4.968 |
| 4-Fluorobutyrylfentanyl | 6.303 | 0.4 | 6.028 | 1.7 | 4.5 | 6.166 |
| Tetrahydrofuranylfentanyl | 3.444 | 0.2 | 3.451 | 3.0 | -0.2 | 3.448 |
| Fentanyl | 7.830 | 0.3 | 7.712 | 1.9 | 1.5 | 7.771 |
| AP | - | - | - | - | - | - |
| MA | 1.789 | 1.3 | 2.015 | 2.0 | -12 | 1.902 |
| MDEA | 1.321 | 0.3 | 1.322 | 1.2 | -0.1 | 1.322 |
| MDMA | 3.284 | 0.7 | 3.325 | 1.2 | -1.2 | 3.305 |
| Ephedrine | 1.667 | 1.3 | 1.667 | 1.6 | 0 | 1.667 |
| MDA | 1.938 | 1.6 | 2.112 | 2.7 | -8.6 | 2.025 |
Table 4 Comparison of LC-MS/MS and GC-MS results
| Drug name | LC-MS/MS (n=3) | GC-MS (n=3) | Deviation/% | Average value/(ng/mg) | ||
|---|---|---|---|---|---|---|
| Average value/(ng/mg) | RSD/% | Average value/(ng/mg) | RSD/% | |||
| Norfentanyl | 1.012 | 1.6 | 1.087 | 3.7 | -7.1 | 1.050 |
| Acetylfentanyl | 4.788 | 0.6 | 4.821 | 2.0 | -0.7 | 4.805 |
| Isobutyrylfentanyl | 4.826 | 0.3 | 4.816 | 1.9 | 0.2 | 4.821 |
| 4-Fluorofentanyl | 5.830 | 0.2 | 5.786 | 1.6 | 0.8 | 5.808 |
| Ocfentanil | 3.188 | 1.1 | 3.031 | 2.2 | 5.1 | 3.110 |
| Thiofentanyl | 5.010 | 0.6 | 4.925 | 2.0 | 1.7 | 4.968 |
| 4-Fluorobutyrylfentanyl | 6.303 | 0.4 | 6.028 | 1.7 | 4.5 | 6.166 |
| Tetrahydrofuranylfentanyl | 3.444 | 0.2 | 3.451 | 3.0 | -0.2 | 3.448 |
| Fentanyl | 7.830 | 0.3 | 7.712 | 1.9 | 1.5 | 7.771 |
| AP | - | - | - | - | - | - |
| MA | 1.789 | 1.3 | 2.015 | 2.0 | -12 | 1.902 |
| MDEA | 1.321 | 0.3 | 1.322 | 1.2 | -0.1 | 1.322 |
| MDMA | 3.284 | 0.7 | 3.325 | 1.2 | -1.2 | 3.305 |
| Ephedrine | 1.667 | 1.3 | 1.667 | 1.6 | 0 | 1.667 |
| MDA | 1.938 | 1.6 | 2.112 | 2.7 | -8.6 | 2.025 |
|
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
